146 related articles for article (PubMed ID: 38162638)
1. Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study.
Wang X; Dian Y; Zhou Q; Deng G; Wei R; Zeng F
Front Immunol; 2023; 14():1320973. PubMed ID: 38162638
[TBL] [Abstract][Full Text] [Related]
2. Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine.
Mao M; Dian Y; Sun Y; Chen W; Zhu W; Deng G
Front Cell Infect Microbiol; 2023; 13():1237277. PubMed ID: 37920449
[TBL] [Abstract][Full Text] [Related]
3. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID 19 infection.
P P; Krishnamurthy V; Kumar TA
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443507
[TBL] [Abstract][Full Text] [Related]
4. Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.
Deng G; Li D; Sun Y; Jin L; Zhou Q; Xiao C; Wu Q; Sun H; Dian Y; Zeng F; Pan P; Shen M
J Med Virol; 2023 Apr; 95(4):e28756. PubMed ID: 37185838
[TBL] [Abstract][Full Text] [Related]
5. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID-19 infection.
Krishnamurthy V; Sujatha KJ; Kumar TA; Phaniraj P; Shankar T; Raj MP
Ann Afr Med; 2022; 21(3):278-282. PubMed ID: 36204916
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
Soni M
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
[TBL] [Abstract][Full Text] [Related]
7. Eosinopenia as an Adverse Marker of Clinical Outcomes in Patients Presenting with Acute Myocardial Infarction.
Alkhalil M; Kearney A; Hegarty M; Stewart C; Devlin P; Owens CG; Spence MS
Am J Med; 2019 Dec; 132(12):e827-e834. PubMed ID: 31152721
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory predictors (eosinophil, C-RP and IL-6) and effectiveness of oral Azvudine tablets treatment in COVID-19 hospitalized patients: A retrospective, self-controlled study.
Zhao Y; Gao G; Li W; Xu Z; Wang X; Chang R
Heliyon; 2023 Nov; 9(11):e21941. PubMed ID: 38034620
[TBL] [Abstract][Full Text] [Related]
9. Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study.
Han X; Gao D; Li C; Yuan X; Cui J; Zhao W; Xie F; Wang K; Liu Y; Muo G; Xi N; Zheng M; Wang R; Xiao K; Zhao D; Zhang X; Han X; Wang B; Zhang T; Xie W; Xie L
BMC Infect Dis; 2024 Jan; 24(1):57. PubMed ID: 38191304
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Analysis of Azvudine in Patients with COVID-19 and Pre-existing Cancer.
Li F; Zheng K; Qi X; Cui K; Yang J; Hao Z
J Cancer; 2024; 15(8):2442-2447. PubMed ID: 38495484
[No Abstract] [Full Text] [Related]
11. Eosinopenia as Predictor of Poor Outcome in Hospitalized COVID-19 Adult Patients from Waves 1 and 2 of 2020 Pandemic.
Cauchois R; Pietri L; Dalmas JB; Koubi M; Capron T; Cassir N; Potere N; Polidoro I; Jean R; Jarrot PA; Andre B; Veit V; Carvelli J; Pauly V; Chanez P; Papazian L; Kaplanski G
Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557676
[TBL] [Abstract][Full Text] [Related]
12. Predictive role of blood eosinophils in adult varicella patients.
Yang L; Zhang W; Shen X; Chang J; Liu M
Epidemiol Infect; 2022 Jun; 150():e127. PubMed ID: 35726529
[TBL] [Abstract][Full Text] [Related]
13. Persistent eosinopenia is associated with in-hospital mortality among older patients: unexpected prognostic value of a revisited biomarker.
Partouche B; Pepin M; de Farcy PM; Kahn JE; Sawczynski B; Lechowski L; Teillet L; Barbot F; Herr M; Davido B
BMC Geriatr; 2021 Oct; 21(1):557. PubMed ID: 34649512
[TBL] [Abstract][Full Text] [Related]
14. Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19: Emulation of a randomized target trial.
Zhou Y; Liu Y; Jiang L; Zhang R; Zhang H; Shi Q; Yang Z; Mao Y; Liu S; Yang Z; Ding J; Zhou Y; Ren B; He L; Zhao X; Li W; Li S; Liu D
J Med Virol; 2023 Dec; 95(12):e29318. PubMed ID: 38112106
[TBL] [Abstract][Full Text] [Related]
15. Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study.
Zhang Y; Cui Y; Shen M; Zhang J; Liu B; Dai M; Chen L; Han D; Fan Y; Zeng Y; Li W; Lin F; Li S; Chen X; Pan P;
Diabetes Res Clin Pract; 2020 Jul; 165():108227. PubMed ID: 32446795
[TBL] [Abstract][Full Text] [Related]
16. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
[TBL] [Abstract][Full Text] [Related]
17. Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.
Cazzaniga M; Fumagalli LAM; D'angelo L; Cerino M; Bonfanti G; Fumagalli RM; Schiavo G; Lorini C; Lainu E; Terragni S; Chiarelli M; Scarazzati C; Bonato C; Zago M
Int J Clin Pract; 2021 Jul; 75(7):e14047. PubMed ID: 33497517
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study.
Eijmael M; Janssens N; le Cessie S; van Dooren Y; Koster T; Karim F
Infection; 2021 Dec; 49(6):1325-1329. PubMed ID: 34625911
[TBL] [Abstract][Full Text] [Related]
19. Azvudine for the Treatment of COVID-19 in Pre-Existing Cardiovascular Diseases: A Single-Center, Real-World Experience.
Wu L; He ZH; Huang L; Guo X; Li XY; Zhang HD; Chen MH
Adv Sci (Weinh); 2024 Mar; ():e2306050. PubMed ID: 38544344
[TBL] [Abstract][Full Text] [Related]
20. Eosinopenia in Children following Traumatic Intracranial Hemorrhage Is Associated with Poor Prognosis and Prolonged Hospital Admission.
Hori YS; Fukuhara T; Aoi M; Namba Y
Pediatr Neurosurg; 2016; 51(2):57-60. PubMed ID: 26636657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
